- Home
- FLNA vs FLL Comparison
FLNA vs FLL Comparison
Compare FLNA & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLNA | FLL |
|---|---|---|
| Founded | 1998 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 50.9M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FLNA | FLL |
|---|---|---|
| Price | $0.65 | $0.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $6.50 | $3.00 |
| AVG Volume (30 Days) | ★ 702.8K | 331.8K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.45 |
| EPS | N/A | ★ N/A |
| Revenue | $41,119,000.00 | ★ $302,376,000.00 |
| Revenue This Year | N/A | $3.39 |
| Revenue Next Year | N/A | $5.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.53 |
| 52 Week Low | $0.64 | $0.87 |
| 52 Week High | $2.03 | $3.37 |
Technical Indicators
Market Signals| Indicator | FLNA | FLL |
|---|---|---|
| Relative Strength Index (RSI) | 34.93 | 17.38 |
| Support Level | N/A | N/A |
| Resistance Level | $1.05 | $2.74 |
| Average True Range (ATR) | 0.04 | 0.13 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 3.74 | 9.06 |
Price Performance
Historical ComparisonAbout FLNA Filana Therapeutics Inc. Common Stock
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
About FLL Full House Resorts Inc.
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.